bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

26 Jun 2024 07:01 CEST

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1265305_PR_bioMerieux_SPOTFIRE_RST_Panel_Mini_FDA_Clearance_20240626.pdf